Dmitry Turbin

Medicine · Health Sciences

30h-index3.6kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(22), Monoclonal and Polyclonal Antibodies Research(15), Breast Cancer Treatment Studies(6), RNA Research and Splicing(5), Genetic factors in colorectal cancer(5)

Publications53 total

Supplementary Slide 3 from Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2023Open Access
Data from Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2023Open Access
Data from Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2023Open Access
Supplementary Figure 1 from Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2023Open Access
Supplementary Figure 1 from Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2023Open Access
Supplementary Slide 3 from Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2023Open Access
Predictors of Outcome in Mammary Adenoid Cystic Carcinoma
The American Journal of Surgical Pathology·2019· 43 cited
Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images
JAMA Network Open·2019· 107 citedOpen Access
Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts
Medical Image Analysis·2018· 171 cited
Biomarker Expression in Pelvic High-grade Serous Carcinoma
International Journal of Gynecological Pathology·2011· 35 cited
Longitudinal Outcome Study of Sessile Serrated Adenomas of the Colorectum: An Increased Risk for Subsequent Right-sided Colorectal Carcinoma
The American Journal of Surgical Pathology·2010· 189 cited
Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer
The Prostate·2010· 30 cited
Subcellular Localization of Activated AKT in Estrogen Receptor- and Progesterone Receptor-Expressing Breast Cancers
American Journal Of Pathology·2010· 42 citedOpen Access
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
Breast Cancer Research and Treatment·2010· 19 cited
Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer
Breast Cancer Research·2010· 67 citedOpen Access
A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors
Modern Pathology·2009· 80 citedOpen Access
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situhybridization (FISH): pathologist assessment compared to quantitative image analysis
BMC Cancer·2009· 85 citedOpen Access
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
Modern Pathology·2008· 285 citedOpen Access
Amplified in breast cancer 1 expression in breast cancer
Histopathology·2008· 12 cited
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Breast Cancer Research·2008· 122 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

David G. Huntsman(25), Maggie C.U. Cheang(15), Erika Yorida(12), Torsten O. Nielsen(12), C. Blake Gilks(9), Sandra E. Dunn(8), Karen A. Gelmon(8), Sunil Badve(7), Samuel Leung(7), Cathy Lee(6), Ashish Rajput(5), Daniel Yokom(5), Helen Jiang(5), Isabelle M. Berquin(5), Peter R. Mertens(5), Thomas Iftner(5), C. Blake Gilks(5), Sam M. Wiseman(5), Robert B. West(4), Mangesh A. Thorat(4)